BVCF III, LP
Sector: Hospital • Location: China
Source: IFC Project Disclosures
IFC is proposing an equity investment in BVCF III, L.P. (the Fund), a private equity fund focusing on growth-stage Life Sciences and Healthcare companies in China. The Fund will make equity investments in early- and growth-stage companies in a range of sectors, including pharmaceuticals, biotechnology, traditional Chinese medicine (TCM), medical technology, healthcare services, and industri
- Status
- Prospective
- Sector
- Hospital, Manufacturing (Industrial)
- Location
- China
- Updated
- 19 Nov 2026
- Source
- IFC Project Disclosures
ConstructChat
Ask ConstructChat about BVCF III, LP
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description |  IFC is proposing an equity investment in BVCF III, L.P. (the Fund), a private equity fund focusing on growth-stage Life Sciences and Healthcare companies in China. The Fund will make equity investments in early- and growth-stage companies in a range of sectors, including pharmaceuticals, biotechnology, traditional Chinese medicine (TCM), medical technology, healthcare services, and industrial and environmental biotechnology. |
Original sector | P-BB - Venture Capital Fund |
Location
Country | China |
Source
Source | IFC Project Disclosures |
URL |
More Details
Record type | Project |
Sector | Hospital, Manufacturing (Industrial) |
Article published date | 2026-09-09 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in China
- Integrated Waste Treatment Project in Xinjiang Uygur Autonomous Region
- Zoetis’ Animal Vaccine Research and Manufacturing Complex, Suzhou
- Merck Serono’s Pharmaceutical Manufacturing Facility, Nantong, China
- WuXi Biologics’ Biologics Manufacturing Centre, Shijiazhuang, China
- Pfizer Global Biotechnology Centre, Hangzhou, China
- Boehringer Ingelheim Biopharmaceuticals Project, Shanghai
- Clover Biopharmaceuticals Biomanufacturing Facility, Changxing, China
- Shanghai CP Guojan API Production Suite, Shanghai
